Gabapentin in Headache Disorders: What Is the Evidence? (Q38591703)

4 September 2017

title

Gabapentin in Headache Disorders: What Is the Evidence? (English)

1 reference

4 September 2017

0 references

1 reference

1 reference

Michael D Perloff

1 reference

4 September 2017

Rachel K Berlin

1 reference

4 September 2017

Marshall Gillette

1 reference

4 September 2017

Matthew J Petersile

1 reference

4 September 2017

Donna Kurowski

1 reference

4 September 2017

publication date

23 September 2015

1 reference

4 September 2017

1 reference

4 September 2017

1 reference

4 September 2017

1 reference

4 September 2017

page(s)

162-171

1 reference

alpha2delta and the mechanism of action of gabapentin in the treatment of pain

4 September 2017

cites work

1 reference

Gabapentin for the Treatment of Postherpetic Neuralgia: A Randomized Controlled Trial

21 January 2018

1 reference

The use of gabapentin for the treatment of postherpetic neuralgia

21 January 2018

1 reference

Gabapentin in postherpetic neuralgia: a randomised, double blind, placebo controlled study

21 January 2018

1 reference

A summary of mechanistic hypotheses of gabapentin pharmacology

21 January 2018

1 reference

Gabapentin is not a GABAB receptor agonist

21 January 2018

1 reference

Does gabapentin act as an agonist at native GABA(B) receptors?

21 January 2018

1 reference

The Effects of Intrathecal and Systemic Gabapentin on Spinal Substance P Release

21 January 2018

1 reference

Pharmacological disruption of calcium channel trafficking by the alpha2delta ligand gabapentin

21 January 2018

1 reference

Identification of the alpha2-delta-1 subunit of voltage-dependent calcium channels as a molecular target for pain mediating the analgesic actions of pregabalin

21 January 2018

1 reference

Pregabalin and gabapentin reduce release of substance P and CGRP from rat spinal tissues only after inflammation or activation of protein kinase C

21 January 2018

1 reference

Dual effects of gabapentin and pregabalin on glutamate release at rat entorhinal synapses in vitro

21 January 2018

1 reference

Outcome reporting in industry-sponsored trials of gabapentin for off-label use

21 January 2018

1 reference

The prophylactic treatment of chronic daily headache

21 January 2018

1 reference

Efficacy of gabapentin in migraine prophylaxis

21 January 2018

1 reference

Gabapentin in the prophylaxis of chronic daily headache: a randomized, placebo-controlled study

21 January 2018

1 reference

Migraine prevalence, disease burden, and the need for preventive therapy

21 January 2018

1 reference

Lost in a jungle of evidence: we need a compass

21 January 2018

1 reference

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

Randomized, double-blind, placebo-controlled, phase II trial of gabapentin enacarbil for migraine prophylaxis.

21 January 2018

1 reference

The 2012 AHS/AAN guidelines for prevention of episodic migraine: a summary and comparison with other recent clinical practice guidelines

21 January 2018

1 reference

The International Classification of Headache Disorders, 3rd edition (beta version)

21 January 2018

1 reference

Drug-resistant cluster headache responding to gabapentin: a pilot study

21 January 2018

1 reference

The use of gabapentin in chronic cluster headache patients refractory to first-line therapy.

21 January 2018

1 reference

Cluster Headache-Acute and Prophylactic Therapy

21 January 2018

1 reference

Cluster headache: diagnosis and treatment

21 January 2018

1 reference

Is gabapentin an effective treatment choice for hemicrania continua?

21 January 2018

1 reference

SUNCT syndrome. A clinical review

21 January 2018

1 reference

EFNS guidelines on the treatment of cluster headache and other trigeminal-autonomic cephalalgias

21 January 2018

1 reference

Short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing

21 January 2018

1 reference

Efficacy of gabapentin in the treatment of SUNCT syndrome.

21 January 2018

1 reference

Gabapentin for prevention of hypobaric hypoxia-induced headache: randomized double-blind clinical trial.

21 January 2018

1 reference

Low-dose gabapentin in treatment of high-altitude headache

21 January 2018

1 reference

The analgesic and antiemetic efficacy of gabapentin or ergotamine/caffeine for the treatment of postdural puncture headache

21 January 2018

1 reference

Gabapentin-responsive idiopathic stabbing headache

21 January 2018

1 reference

Epicrania fugax: ten new cases and therapeutic results

21 January 2018

1 reference

Gabapentin leads to remission of somatoform pain disorder with major depression

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/PME.12931

0 references

1 reference